Skip to main content
SpringerLink
Log in

Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study

  • Original Research Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Introduction

Opioid prescribing trends have been investigated in many countries. However, the patterns of over-the-counter purchases of opioids without a prescription, such as codeine combinations, are mostly unknown.

Objective

We aimed to assess national sales and expenditure trends of over-the-counter codeine-containing products purchased in countries with available data over 6 years.

Methods

We conducted a retrospective observational study using electronic point-of-sale data from the human data science company, IQVIA, for countries that had such data, including Argentina, Belgium, Brazil, Bulgaria, Canada, Croatia, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, the Netherlands, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, South Africa, Spain, Switzerland, Thailand, the UK, and the USA. We calculated annual mean sales (dosage units/1000 population) and public expenditure (£/1000 population) for each country between April 2013 and March 2019 and adjusted for data coverage reported by IQVIA. We quantified changes over time and the types of products sold.

Results

In total, 31.5 billion dosage units (adjusted: 42.8 billion dosage units) of codeine, costing £2.55 billion (adjusted: £3.68 billion), were sold over the counter in 31 countries between April 2013 and March 2019. Total adjusted sales increased by 11% (from 3911 dosage units/1000 population in 2013 to 4358 in 2019) and adjusted public expenditure increased by 72% (from £263/1000 in 2013 to £451/1000 in 2019). Sales were not equally distributed; South Africa sold the most (36 mean dosage units/person), followed by Ireland (30 mean dosage units/person), France (20 mean dosage units/person), the UK (17.2 mean dosage units/person), and Latvia (16.8 mean dosage units/person). Types of products (n = 569) and formulations (n = 12) sold varied.

Conclusion

In many parts of the world, substantial numbers of people may be purchasing and consuming codeine in over-the-counter products. Clinicians should ask patients about their use of over-the-counter products, and public health measures are required to improve the collection of sales data and the safety of such products.

Study Protocol Pre-registration

https://osf.io/ay4mc. The pre-print version of this work is available on medRxiv: https://doi.org/10.1101/2021.04.21.21255888.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Curtis HJ, Croker R, Walker AJ, Richards GC, Quinlan J, Goldacre B. Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study. Lancet Psychiatry. 2019;6:140–50. https://doi.org/10.1016/S2215-0366(18)30471-1.

    Article  PubMed  Google Scholar 

  2. Goodman-Meza D, Friedman J, Kalmin MM, Aguilar-Posada E, Seamans MJ, Velazquez-Moreno S, et al. Geographical and socioeconomic disparities in opioid access in Mexico, 2015–19: a retrospective analysis of surveillance data. Lancet Public Health. 2021;6:e88-96. https://doi.org/10.1016/S2468-2667(20)30260-7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kalkman GA, Kramers C, Van Dongen RT, Van Den Brink W, Schellekens A. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health. 2019;4:498–505. https://doi.org/10.1016/S2468-2667(19)30128-8.

    Article  Google Scholar 

  4. Krawczyk N, Greene MC, Zorzanelli R, Bastos FI. Rising trends of prescription opioid sales in contemporary Brazil, 2009–2015. Am J Public Health. 2018. https://doi.org/10.2105/AJPH.2018.304341.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lambert AP. Life-threatening hypokalaemia from abuse of Nurofen Plus. J R Soc Med. 2005;98:21–21. https://doi.org/10.1258/jrsm.98.1.21.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Frei MY, Nielsen S, Dobbin MDH, Tobin CL. Serious morbidity associated with misuse of over-the-counter codeine–ibuprofen analgesics: a series of 27 cases. Med J Aust. 2010;193:294–6. https://doi.org/10.5694/j.1326-5377.2010.tb03911.x.

    Article  PubMed  Google Scholar 

  7. Carney T, Wells J, Parry CDH, McGuinness P, Harris R, Van Hout MC. A comparative analysis of pharmacists’ perspectives on codeine use and misuse—a three country survey. Subst Abus Treat Prev Policy. 2018. https://doi.org/10.1186/s13011-018-0149-2.

    Article  Google Scholar 

  8. Kimergård A, Foley M, Davey Z, Dunne J, Drummond C, Deluca P. Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey. QJM An Int J Med. 2017;110:559–64. https://doi.org/10.1093/qjmed/hcx076.

    Article  Google Scholar 

  9. Agaba E, Agaba P, Wigwe C. Use and abuse of analgesics in Nigeria: a community survey. Niger J Med. 2004;13:379–82.

    CAS  PubMed  Google Scholar 

  10. Orriols L, Gaillard J, Lapeyre-Mestre M, Roussin A. Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France. Drug Saf. 2009;32:859–73. https://doi.org/10.2165/11316590-000000000-00000.

    Article  CAS  PubMed  Google Scholar 

  11. Cooper RJ. “I can” t be an addict. I am.’ Over-the-counter medicine abuse: a qualitative study. BMJ Open. 2013;3:2913. https://doi.org/10.1136/bmjopen-2013-002913.

    Article  Google Scholar 

  12. Van Hout MC, Rich E, Dada S, Bergin M. “Codeine Is My Helper”: misuse of and dependence on codeine-containing medicines in South Africa. Qual Health Res. 2017. https://doi.org/10.1177/1049732315613764.

    Article  PubMed  Google Scholar 

  13. Kinnaird E, Kimergård A, Jennings S, Drummond C, Deluca P. From pain treatment to opioid dependence: a qualitative study of the environmental influence on codeine use in UK adults. BMJ Open. 2019;9: e025331. https://doi.org/10.1136/bmjopen-2018-025331.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Roxburgh A, Hall WD, Burns L, Pilgrim J, Saar E, Nielsen S, et al. Trends and characteristics of accidental and intentional codeine overdose deaths in Australia. Med J Aust. 2015;203:299.e1-299.e7.

    Article  Google Scholar 

  15. Schifano F, Zamparutti G, Zambello F, Oyefeso A, Deluca P, Balestrieri M, et al. Review of deaths related to analgesic- and cough suppressant-opioids; England and Wales 1996–2002. Pharmacopsychiatry. 2006. https://doi.org/10.1055/s-2006-949149.

    Article  PubMed  Google Scholar 

  16. Mill D, Johnson JL, Cock V, Monaghan E, Hotham ED. Counting the cost of over-the-counter codeine containing analgesic misuse: a retrospective review of hospital admissions over a 5 year period. Drug Alcohol Rev. 2018;37:247–56. https://doi.org/10.1111/dar.12595.

    Article  PubMed  Google Scholar 

  17. Derry S, Moore RA, McQuay HJ. Single dose oral codeine, as a single agent, for acute postoperative pain in adults. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.cd008099.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD002116.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Molassiotis A, Bailey C, Caress A, Tan JY. Interventions for cough in cancer. Cochrane Database Syst Rev. 2015. https://doi.org/10.1002/14651858.CD007881.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Derry S, Karlin SM, Moore RA. Single dose oral ibuprofen plus codeine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2015. https://doi.org/10.1002/14651858.CD010107.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Toms L, Derry S, Moore RA, McQuay HJ. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev. 2009. https://doi.org/10.1002/14651858.CD001547.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015. https://doi.org/10.1002/14651858.CD010794.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Abdel Shaheed C, Maher CG, McLachlan AJ. Efficacy and safety of low-dose codeine-containing combination analgesics for pain. Clin J Pain. 2019;35:836–43. https://doi.org/10.1097/AJP.0000000000000746.

    Article  PubMed  Google Scholar 

  24. Frei MY, Nielsen S, Dobbin MDH, Tobin CL. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust. 2010;193:294–6. https://doi.org/10.5694/j.1326-5377.2010.tb03911.x.

    Article  PubMed  Google Scholar 

  25. WHO. Pre-Review Report: Preparations of codeine listed in Schedule III of the 1961 Single Convention on Narcotic Drugs [Internet]. Geneva; 2019. https://www.who.int/medicines/access/controlled-substances/Final_codeine.pdf.

  26. United Nations. United Nations Single Convention on Narcotic Drugs, 1961 [Internet]. 1961 [cited 2021 Jan 20]. https://www.emcdda.europa.eu/drugs-library/single-convention-narcotic-drugs-1961_en. .

  27. Wilkes D. France restricts dextromethorphan and codeine [Internet]. OTC Toolbox. 2017 [cited 2021 Jan 24]. https://www.otctoolbox.com/industry-news/france-restricts-dextromethorphan-and-codeine.

  28. Kirby T. The end of over-the-counter codeine in Australia. Lancet. 2018. https://doi.org/10.1002/pds.3931/abstract.

    Article  PubMed  Google Scholar 

  29. Foley M, Harris R, Rich E, Rapca A, Bergin M, Norman I, et al. The availability of over-the-counter codeine medicines across the European Union. Public Health. 2015;129:1465–70. https://doi.org/10.1016/j.puhe.2015.06.014.

    Article  CAS  PubMed  Google Scholar 

  30. Lo MY, Ong MW, Lin JG, Sun WZ. Codeine consumption from over-the-counter anti-cough syrup in Taiwan: a useful indicator for opioid abuse. Acta Anaesthesiol Taiwan. 2015;53:135–8. https://doi.org/10.1016/j.aat.2015.10.001.

    Article  PubMed  Google Scholar 

  31. Cairns R, Schaffer AL, Brown JA, Pearson S, Buckley NA. Codeine use and harms in Australia: evaluating the effects of re-scheduling. Addiction. 2020;115:451–9. https://doi.org/10.1111/add.14798.

    Article  PubMed  Google Scholar 

  32. Gisev N, Nielsen S, Cama E, Larance B, Bruno R, Degenhardt L. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia. Eur J Clin Pharmacol. 2016;72:469–94. https://doi.org/10.1007/s00228-015-1995-8.

    Article  PubMed  Google Scholar 

  33. Consumer Health—IQVIA [Internet]. [cited 2020 Jun 12]. https://www.iqvia.com/solutions/industry-segments/consumer-health.

  34. Hsia Y, Sharland M, Jackson C, Wong ICK, Magrini N, Bielicki JA. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries. Lancet Infect Dis. 2019;19:67–75. https://doi.org/10.1016/S1473-3099(18)30547-4.

    Article  PubMed  Google Scholar 

  35. Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen RJ, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816–26. https://doi.org/10.1016/S0140-6736(19)32317-7.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Guy GP, Haegerich TM, Evans ME, Losby JL, Young R, Jones CM. Vital signs: pharmacy-based naloxone dispensing—United States, 2012–2018. MMWR Morb Mortal Wkly Rep. NLM (Medline). 2019;68:679–86. http://www.cdc.gov/mmwr/volumes/68/wr/mm6831e1.htm?s_cid=mm6831e1_w.

  37. The World Bank. Population data [Internet]. 2019 [cited 2020 May 28]. https://data.worldbank.org/indicator/SP.POP.TOTL?end=2018&start=1960&view=chart.

  38. PANDAS Development Team. pandas-dev/pandas: PANDAS. Zenodo; 2020.

  39. Waskom M. mwaskom/seaborn. Zenodo; 2020.

  40. Hunter J. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2009;9:90–5.

    Article  Google Scholar 

  41. Richards G. georgiarichards/otc_codeine [Internet]. GitHub. 2020 [cited 2021 Apr 3]. p. https://doi.org/10.5281/zenodo.5720700. https://github.com/georgiarichards/otc_codeine.

  42. Richards G. Sales of over-the-counter (OTC) codeine-containing products in 31 countries, 2013–2019 [Internet]. OSF Regist. 2020 [cited 2021 Apr 3]. https://osf.io/ay4mc.

  43. Richards GC, Mahtani KR, Goldacre B, Heneghan C. 135 Trends and variation in the sales of over-the-counter analgesics: a protocol for a retrospective database study and policy review. BMJ Evid Based Med. 2018. https://doi.org/10.1136/bmjebm-2018-111070.135.

    Article  Google Scholar 

  44. Richards GC, Hobbs R, Aronson JK, Heneghan C. Sales of over-the-counter (OTC) codeine-containing products [Internet]. OSF. 2021 [cited 2021 Jan 4]. https://osf.io/yt6bf/.

  45. Kamerman PR, Bradshaw D, Laubscher R, Pillay-Van Wyk V, Gray GE, Mitchell D, et al. Almost 1 in 5 South African adults have chronic pain: a prevalence study conducted in a large nationally representative sample. Pain. 2020;161:1629–35. https://doi.org/10.1097/J.PAIN.0000000000001844.

    Article  PubMed  Google Scholar 

  46. Foley M, Carney T, Rich E, Dada S, Mburu C, Parry C. A study of medical professionals’ perspectives on medicines containing codeine in South Africa. S Afr J Psychiatry. 2018. https://doi.org/10.4102/sajpsychiatry.v24i0.1162.

    Article  Google Scholar 

  47. Dada S, Burnhams NH, van Hout MC, Parry CDH. Codeine misuse and dependence in South Africa – learning from substance abuse treatment admissions. S Afr Med J. 2015;105:776–9. https://doi.org/10.7196/SAMJnew.8172.

    Article  CAS  PubMed  Google Scholar 

  48. VICE Video. Zimbabwe’s Codeine Cough Syrup Epidemic [Internet]. 2018 [cited 2021 Feb 1]. https://video.vice.com/en_uk/video/vice-zimbabwes-codeine-cough-syrup-epidemic-1-104/5c373790be407707904345c1.

  49. Foley M, Carney T, Harris R, Fitzpatrick E, Rapca-Veillet A, Van Hout MC. Medicines containing codeine: perspectives of medical professionals in the Republic of Ireland. Ir J Med Sci. 2017;186:555–63. https://doi.org/10.1007/s11845-016-1546-z.

    Article  CAS  PubMed  Google Scholar 

  50. Van Hout MC, Horan A, Santlal K, Rich E, Bergin M. “Codeine is my companion”: misuse and dependence on codeine containing medicines in Ireland. Ir J Psychol Med. 2018;35:275–88. https://doi.org/10.1017/ipm.2015.60.

    Article  PubMed  Google Scholar 

  51. Birchall E, Perry IJ, Corcoran P, Daly C, Griffin E. The impact of guidance on the supply of codeine-containing products on their use in intentional drug overdose. Eur J Public Health. 2021. https://doi.org/10.1093/eurpub/ckab082/6285556.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Nomura K, Kitagawa Y, Yuda Y, Takano-Ohmuro H. Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan. Risk Manag Healthc Policy. 2016;9:173–83. https://doi.org/10.2147/RMHP.S98099.

    Article  PubMed  PubMed Central  Google Scholar 

  53. de Villiers J. Here are the over-the-counter medicines you may need a prescription for in future—including Adcodol and Nurofen Plus [Internet]. Bus. Insid. SA. 2020 [cited 2021 Jan 25]. https://www.businessinsider.co.za/codeine-containing-medicines-in-south-africa-to-be-affected-by-south-african-health-products-regulatory-authoritys-up-scheduling-move-2020-1.

  54. Ridley D. Swiss experts advise codeine reverse-switch [Internet]. LinkedIn. 2018 [cited 2021 Jan 25]. https://www.linkedin.com/pulse/swiss-experts-advise-codeine-reverse-switch-david-ridley/.

  55. MHRA. UK regulator strengthens opioid warnings [Internet]. Vigil. Saf. alerts Guid. 2020 [cited 2021 Jan 20]. https://www.gov.uk/government/news/uk-regulator-strengthens-opioid-warnings.

  56. Government of Canada. Forward Regulatory Plan 2019–2021: Regulations Amending the Narcotic Control Regulations under the Controlled Drugs and Substances Act to make all products containing codeine available by prescription only while ensuring access to these medications [Internet]. 2019 [cited 2021 Jan 28]. https://www.canada.ca/en/health-canada/corporate/about-health-canada/legislation-guidelines/acts-regulations/forward-regulatory-plan/plan/codeine-prescription.html.

  57. Schaffer AL, Cairns R, Brown JA, Gisev N, Buckley NA, Pearson SA. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine. Med J Aust. 2020;212:321–7.

    Article  Google Scholar 

  58. Fadhil I, Lyons G, Payne S. Barriers to, and opportunities for, palliative care development in the Eastern Mediterranean Region. Lancet Oncol. 2017. https://doi.org/10.1016/S1470-2045(17)30101-8.

    Article  PubMed  Google Scholar 

  59. Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016. https://doi.org/10.1016/S0140-6736(16)00161-6.

    Article  PubMed  Google Scholar 

  60. Richards GC, Aronson JK, Mahtani KR, Heneghan C. Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories. Br J Pain. 2021. https://doi.org/10.1177/20494637211013052.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Richards GC, Aronson JK, Heneghan C, Mahtani KR, Koshiaris C, Persaud N. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists. BMJ Glob Heal. 2020;5:1–8. https://doi.org/10.1136/bmjgh-2020-003563.

    Article  Google Scholar 

  62. Marsh S. “I could get 500 tablets a month”: the ease of buying opiates online [Internet]. Guard. 2019 [cited 2021 Jan 24]. https://www.theguardian.com/society/2019/apr/26/i-could-get-500-tablets-a-month-ease-of-buying-opiates-online.

  63. NHS England. The Controlled Drugs (Supervision of Management and Use) Regulations 2013 [Internet]. Single Oper. Model. 2013 [cited 2021 Apr 19]. https://www.england.nhs.uk/wp-content/uploads/2013/11/som-cont-drugs.pdf.

  64. PSNC. Controlled Drug prescription forms and validity [Internet]. Pharm. Serv. Negot. Comm. 2020 [cited 2021 Apr 19]. https://psnc.org.uk/dispensing-supply/dispensing-controlled-drugs/controlled-drug-prescription-forms-and-validity/.

  65. INCB. Narcotic Drugs—Estimated World Requirements for 2020—Statistics for 2018 [Internet]. Vienna; 2019 [cited 2020 Oct 25]. https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf.

Download references

Acknowledgements

The authors thank the Primary Care Research Trust of Birmingham and Midlands Research Practices Consortium for providing the funding to purchase the sales data from IQVIA.

Author information

Authors and Affiliations

  1. Global Centre on Healthcare and Urbanisation, Kellogg College, University of Oxford, 60-62 Banbury Road, Oxford, OX2 6PN, UK

    Georgia C. Richards & Carl Heneghan

  2. Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Woodstock Road, Oxford, OX2 6GG, UK

    Georgia C. Richards, Jeffrey K. Aronson & Carl Heneghan

  3. EBM Datalab, Nuffield Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford, OX2 6GG, UK

    Brian MacKenna & Ben Goldacre

  4. Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Woodstock Road, Oxford, OX2 6GG, UK

    F. D. Richard Hobbs

Authors
  1. Georgia C. Richards
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey K. Aronson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian MacKenna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ben Goldacre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. D. Richard Hobbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carl Heneghan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georgia C. Richards.

Ethics declarations

Funding

This research was supported by the Primary Care Research Trust of Birmingham and Midlands Research Practices Consortium, who provided the funding to purchase the sales data from IQVIA.

Conflict of interest

GCR was financially supported by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR), the Naji Foundation, and the Rotary Foundation to study for a Doctor of Philosophy (2017-2020) but no longer has any financial conflicts of interest. GCR is an associate editor of BMJ Evidence Based Medicine. JKA has published articles and edited textbooks on adverse drug reactions and interactions and has often given medicolegal advice, including appearances as an expert witness in coroners' courts, often dealing with the adverse effects of opioids. BM works for NHS England as a pharmacist adviser. BG has received research funding from the Laura and John Arnold Foundation, the NIHR, the NIHR SPCR, the NIHR Oxford Biomedical Research Centre, the Mohn–Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, and the WHO; he also receives personal income from speaking and writing for lay audiences on the misuse of science. FDRH acknowledges part support from the NIHR SPCR, the NIHR Applied Research Collaboration Oxford Thames Valley, and the NIHR Oxford Oxford University Hospitals Biomedical Research Centre (OUH BRC). CH is an NIHR senior investigator and has received expenses and fees for his media work, expenses from the WHOand the US FDA, and holds grant funding from the NIHR SPCR and the NIHR SPCR Evidence Synthesis Working Group (project 380), the NIHR BRC Oxford and the WHO. On occasion, CH receives expenses for teaching evidence-based medicine and is also paid for his general practitioner work in the NHS out of hours (contract with Oxford Health NHS Foundation Trust). CH is the Director of the Centre for Evidence-Based Medicine. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.

Availability of data and material

Study materials are available on an open repository [44] (https://osf.io/yt6bf/). We cannot openly share the data because of contractual agreements with IQVIA, but the data can be accessed directly from IQVIA, which will require a fee.

Code availability

Our statistical code is openly available at GitHub [41] (https://github.com/georgiarichards/otc_codeine).

Author contributions

GCR devised the research question; designed the methods; wrote the protocol; conducted a literature search; sourced, cleaned, managed, and analysed the data; created the figures; and wrote the first draft of the manuscript. JKA and CH reviewed the protocol and preliminary findings and provided supervisory support. FDRH reviewed the protocol and facilitated the grant application. BM reviewed preliminary findings and contributed to the interpretation of data. BG provided supervisory support. All authors read and approved the final version.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

All authors read and approved the final manuscript and consent to submit the manuscript for publication.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 2940 kb)

Supplementary file2 (DOCX 35 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Richards, G.C., Aronson, J.K., MacKenna, B. et al. Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study. Drug Saf 45, 237–247 (2022). https://doi.org/10.1007/s40264-021-01143-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-021-01143-2

Search

Navigation